Key Highlights
- Treasury Department pledged to expand purchases of long-term government securities by at least 100% beginning September, driving yields down
- Bitcoin rallied more than 9%, breaking through the $70,000 threshold for the first time since the beginning of June
- Major US equity indicesāthe S&P 500, Dow Jones, and Nasdaqāall advanced 0.2% Wednesday, ending a three-session decline
- Minutes from the Federal Reserve’s July policy meeting revealed three members voted against the prevailing decision, preferring a rate increase
- America’s national debt surpassed the $40 trillion mark while President Trump announced plans for aggressive economic measures against Iran
The cryptocurrency market experienced a significant boost as [[LINK_START_1]]Bitcoin[[LINK_END_1]] crossed the $70,000 threshold following an unexpected Treasury Department announcement regarding expanded government bond acquisitions. Equity markets stabilized while government bond yields retreated from recent highs.
The Treasury Department revealed plans to expand its acquisition program for longer-maturity government securities by a minimum of 100% beginning in September. This strategic intervention helped settle a bond market rout that had been creating headwinds for equity investors throughout the week.
Yields on the 10-year Treasury note declined approximately 5 basis points to settle at 4.65%. The 30-year bond yield experienced a sharper decline of 9 basis points, landing at 5.19%. Declining yields typically provide relief for risk-sensitive assets including equities and digital currencies.
[[LINK_START_1]]Bitcoin[[LINK_END_1]] demonstrated a powerful response to the news. The leading cryptocurrency surged more than 9% intraday, reclaiming the $70,000 price level for the first time since the opening days of June.
Futures contracts pointed to continued stability heading into Thursday’s session. S&P 500 futures edged modestly higher, Dow futures remained essentially unchanged, and Nasdaq-100 futures climbed approximately 0.2%.

Federal Reserve Minutes Reveal Policy Division
Wednesday brought the release of Federal Reserve meeting minutes from the July 28-29 policy gathering. The documents disclosed that three committee members cast dissenting votes favoring a 25-basis-point rate increase, representing a more restrictive monetary policy stance than the market anticipated.
Multiple Fed policymakers indicated that additional monetary tightening might prove necessary should inflation remain persistently above the central bank’s 2% objective. The Federal Open Market Committee maintained its benchmark interest rate in the 3.50% to 3.75% range at the conclusion of that meeting.
Fed Chair Kevin Warsh had previously expressed his preference for allowing market forces to contribute to tightening financial conditions. Treasury Secretary Scott Bessent’s bond purchase initiative may create complications for that strategy.
Financial markets appeared relatively unfazed by the hawkish undertones in the Fed minutes. The Treasury’s bond market intervention proved to be the dominant influence on investor sentiment.
Energy Prices, Geopolitical Tensions, and Fiscal Concerns
Oil prices commanded significant market attention as well. International crude benchmarks climbed back toward the $92 per barrel level as expectations for a rapid resolution to US-Iran tensions diminished. Elevated energy prices could contribute to sustained inflationary pressures.
President Trump utilized his Truth Social platform to announce forthcoming “Economic D-Day” initiatives targeting Iran, describing plans for comprehensive economic warfare and international isolation measures at an unprecedented magnitude.
America’s total national debt breached the $40 trillion threshold, having more than doubled over approximately the past ten years. This fiscal landmark intensified ongoing discussions about the sustainability of US government finances.
Among individual equity movers, Moderna experienced an extraordinary rally of nearly 177% following the release of encouraging clinical trial data for a customized mRNA-based cancer treatment developed in partnership with Merck. The development provided a substantial boost to the broader healthcare sector, which advanced 3.5%.
Walmart is scheduled to release quarterly earnings results Thursday morning. Wall Street analysts anticipate solid performance, though revenue growth is expected to moderate from previous quarters.





